Target intelligence / Profile preview

Beta-tubulin (parasitic) (β-tubulin)

Target
β-tubulin
Molecular classification
Cytoskeletal protein, Tubulin superfamily member, Microtubule component
01

Overview

Parasitic β-tubulin is a core component of microtubules in protozoan and helminth parasites, structurally similar to β-tubulin in other eukaryotes. Together with α-tubulin, it forms obligate α/β heterodimers, which polymerize to build dynamic microtubules essential for mitosis, morphology, intracellular transport, motility, and cell division[3][4][6]. β-Tubulin's essentiality makes it a validated target for antiparasitic drugs, especially benzimidazoles, which selectively disrupt parasite microtubules by binding to β-tubulin and inhibiting polymerization, leading to cytoskeletal collapse and parasite death[6][4]. β-Tubulin can elicit protective immune responses and serve as a biomarker for infection[4]. Drug efficacy and toxicity are influenced by the high degree of evolutionary conservation between parasitic and host β-tubulin, underlying challenges of drug selectivity and resistance mutations[6][4].

Other names
Beta-tubulinβ-tubulinparasite β-tubulinTrypanosoma β-tubulinPlasmodium β-tubulinToxoplasma β-tubulinEchinococcus β-tubulinapicomplexan β-tubulin
02

Mechanism of action

Drugs such as benzimidazoles bind to β-tubulin, inhibiting microtubule polymerization, disrupting cytoskeleton assembly, and blocking cell division in parasites[6][4].

03

Biological functions

Cell divisionMaintenance of cellular morphologyMotilityIntracellular transportSignal transductionMitosis
04

Disease associations

Infection (parasitic diseases such as malaria, leishmaniasis, trypanosomiasis, echinococcosis, toxoplasmosis)
05

Safety considerations

Selectivity: Drugs targeting β-tubulin may also affect host (human) tubulin, leading to potential toxicity.Resistance: Mutations in parasite β-tubulin can confer resistance to benzimidazoles and related drugs.Off-target effects due to tubulin conservation between hosts and parasites.
06

Interacting drugs

Benzimidazoles (e.g., albendazole, mebendazole)

3 more in the full profile.

07

Biomarkers

Circulating parasite β-tubulin as a diagnostic antigen[4]Antibody response to parasite β-tubulin for infection monitoring[4]

Beyond the preview

Go deeper on Beta-tubulin (parasitic) (β-tubulin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-tubulin (parasitic) (β-tubulin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call